Risperdal - News Articles

Behavioral Health Central is Offline


The six-month trial will compare zicronapine with risperidone with the aim of measuring their efficacy and relative impact on key metabolic parameters. ...
H Lundbeck initiates Zicronapine Phase III clinical trial - Pharmaceutical Business Review


The study aims to measure the efficacy of Zicronapine and risperidone and their relative impact on key metabolic parameters. In the trial, the patients will be randomly assigned to Zicronapine (7.5mg/day) or risperidone (5mg/day) treatment in a 1:1 ratio. Lundbeck Development head and executive ...
On Mental Illness: It Takes Time. Category: Columns from The Berkeley Daily Planet


If you take a drug called, Zyprexa, or another one called Risperdal, get ready to schedule in meetings with the health educator for the diabetes you will soon have. Medication induced diabetes will entail a radical change in how you live. There will be more time ...
Article > NICE sticks with Protelos decision; OK for Abilify


The cost regulator has deemed Abilify aa cost-effective use of NHS resources when used in patients who cannot take Johnson & Johnson's Risperdal ...
J.P. Morgan Assigns Johnson & Johnson Neutral Rating (JNJ) | Benzinga.com


on multiple fronts, including in 2008-09 generic competition for Risperdal and Topamax and the loss of significant DES share from increased competition. In 2010, economic pressures weighed on both the Medical Device and Consumer segments to a degree few had anticipated, ...
Do Psychiatric Medications Poison Your Brain? - AOL Health


Whitaker agrees that drugs like the antipsychotic Risperdal might help quell paranoid delusions over the short term, but he argues that over years of use, the drug may actually worsen the illness. Somehow, he believes, psychiatric drugs alter brain chemistry in such a way ...
SureGene and the Medco Research Institute(TM) Enter a Collaboration to Evaluate the Ability of Genetic Biomarkers to Enhance Drug Selection for Serious Mental Health Illnesses. - MarketWatch


SureGene's genetic test has demonstrated the ability to stratify drug efficacy of atypical antipsychotics, such as olanzapine and risperidone. Through their collaboration, the companies will conduct the REST study - Relative Effectiveness of Schizophrenia Therapy - a prospectively ...
Log In Problems


with 1 of 7 oral antipsychotics: chlorpromazine hydrochloride, sulpiride, clozapine, risperidone, olanzapine, quetiapine fumarate, or aripiprazole. ...
News - Monthly Paliperidone Palmitate Noninferior to Biweekly Risperidone in Improving PANSS Total Score in Schizophrenia: Presented at ECNP


AMSTERDAM, the Netherlands -- August 31, 2010 -- Paliperidone palmitate is noninferior to risperidone long-acting injectable (LAI) in improving Positive and Negative Syndrome Scale (PANSS) total score over 13 weeks of treatment in patients with schizophrenia, researchers ...
News - Better Remission Rates Achieved With Risperidone Injection Than Conventional Depot Antipsychotics for Schizophrenia: Presented At ECNP


AMSTERDAM, the Netherlands -- September 3, 2010 -- Treatment with risperidone long-acting injection (LAI) for 54 months led to significantly higher remission rates compared with zuclopenthixol or fluphenazine treatment in patients with schizophrenia, researchers reported here on August ...
New York Autism Insurance Bill: Protects and Serves Whom? - AGE OF AUTISM


Mr. Bell once led the charge for marketing Risperdal to all children affected by autism - those deemed irritable - in other words, all children. His bio, from the Autism Speaks website, states: “Peter joined Cure Autism Now in 2004 following a successful 12-year ...
Antipsychotics Are Not Appropriate for a 2 Year Old | World of Psychology


Last week, The New York Times covered the story of Kyle Warren, a boy who began risperidone (Risperdal) treatment at age 2. Yes, you read the right — age 2 pulling my sister’s hair when she was angry. With consistent, firm, loving parents they gradually gained more self control ...
UK's NICE wants more data on schizophrenia drug | Reuters


including Johnson & Johnson's Risperdal or risperidone, Eli Lilly and Co's Zyprexa or olanzapine, AstraZeneca's Seroquel or quetiapine and Novartis's ...
Going through a lot right now | Gather


But no, he decides to put me on a drug called Risperidone to somewhat sedate me through this for a temporary fix. My son was on this medication a few years ago and he lay on the couch for three days awake some of the time, but pretty much out ...
In This Issue -- 167 (6): A16 Data Supplement - AJP Audio June 2010 -- Am J Psychiatry


a trial of risperidone for maintenance treatment of schizophrenia; recommendations for antipsychotic dosing based on international expert consensus; a 10-year prospective study that tracked remission and recovery from borderline personality disorder in a group of hospitalized patients; ...
Antipsychotic Dosing: Still a Work in Progress -- Remington 167 (6): 623 -- Am J Psychiatry


Notably, the average dose of risperidone used for acute treatment in this study was 4.3 mg/day; thus, the "maintenance" dose in the two groups where it was decreased approximated 2 mg daily. While this dose may be suitable for certain individuals or ...
Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial -- Wang et al. 167 (6): 676 -- Am J Psychiatry


Conclusions: Patients who continued to receive the full risperidone dose used for their acute episode had fewer relapses than those who had dose reductions ...
APA 2010: new long-term data confirm potential of depot formulations | TradingMarkets.com


In a 13-week double blind comparative efficacy trial for Invega Sustenna against Risperdal Consta (risperidone) and placebo, Invega Sustenna was found to be superior to placebo in mean PANSS scores. In both trials adverse events were not common, although headaches, agitation, akathisia ...
GPSG Brazil Installs LIMS-Chromatography System


Tylex tablets, Nizoral tablets, Tylenol drops, Nizoral cream and shampoo and imported products such as Eprex and Risperdal tablets. In addition to holding a strategic position in the production of solids, liquids, creams and shampoos, GPSG Brazil imports ...
J&J Wins Dismissal of Pennsylvania Risperdal Lawsuit (Update2) - BusinessWeek


The Pennsylvania case was the first of 10 lawsuits over J&J's Risperdal marketing practices filed by states to go before a jury. A West Virginia judge last year ordered J&J and Janssen to pay that state $3.95 million on a similar claim. ...
Want to contact a Risperdal attorney in Washington, DC?...Get a free case evaluation from one of our Risperdal attorneys in Washington, DC now.

Pages:   1   2   Next

Need A Risperdal Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Risperdal attorney in Washington, DC?...Get a free case evaluation from one of our Risperdal attorneys in Washington, DC now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Risperdal Case - Submit Your Information Below

Do you need legal assistance with your Risperdal case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Risperdal Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.